	US 11,754,753 B2
	Antioxidant contact lens
Inna Maltseva, San Francisco, CA (US); Nancy J. Keir, Pleasanton, CA (US); Andrew Luk, Pleasanton, CA (US); and Victoria Rogers, Pleasanton, CA (US)
Assigned to COOPERVISION INTERNATIONAL LIMITED, Fareham (GB)
Filed by CooperVision International Limited, Fareham (GB)
Filed on Apr. 13, 2021, as Appl. No. 17/228,748.
Claims priority of provisional application 63/015,765, filed on Apr. 27, 2020.
Prior Publication US 2021/0333436 A1, Oct. 28, 2021
Int. Cl. G02B 1/04 (2006.01); A45C 11/00 (2006.01); A61K 9/00 (2006.01); A61K 31/355 (2006.01); C08J 3/075 (2006.01); C08K 5/1545 (2006.01)

CPC G02B 1/043 (2013.01) [A45C 11/005 (2013.01); A61K 9/0051 (2013.01); A61K 31/355 (2013.01); C08J 3/075 (2013.01); C08K 5/1545 (2013.01); C08J 2333/26 (2013.01); C08J 2383/04 (2013.01)]

10 Claims

1. An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and amount of vitamin E embedded within the silicone hydrogel effective to provide at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, wherein the antioxidant contact lens is free of a bioactive agent having a release profile attenuated by the vitamin E.